Amgen’s cancer sales to grow in 2012, CEO-to-be reports

SAN FRANCISCO - Amgen Inc.,the world’s largest biotechnology company with a facility in West Greenwich, will see revenue accelerate this year as sales of its cancer medicines grow and win wider regulatory approval, the next CEO said. Robert Bradway, the company’s president and chief operating officer, will replace CEO Kevin Sharer, who is retiring, in…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -